Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jiang, 2002, Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, 418, 41, 10.1038/nature00870
Petersen, 1999, Bone marrow as a potential source of hepatic oval cells, Science, 284, 1168, 10.1126/science.284.5417.1168
Prockop, 2003, One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues, Proc Natl Acad Sci USA, 100, 11917, 10.1073/pnas.1834138100
Schwartz, 2002, Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells, J Clin Invest, 109, 1291, 10.1172/JCI0215182
Ryan, 2005, Mesenchymal stem cells avoid allogeneic rejection, J Inflamm (Lond), 2, 8, 10.1186/1476-9255-2-8
Mastri, 2014, Enhancing the efficacy of mesenchymal stem cell therapy, World J Stem Cells, 6, 82, 10.4252/wjsc.v6.i2.82
Sharma, 2014, Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices, Transfusion, 54, 1418, 10.1111/trf.12421
Friedenstein, 1966, Osteogenesis in transplants of bone marrow cells, J Embryol Exp Morphol, 16, 381
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Bajpai, 2012, Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells, Stem Cell Res (Amst), 8, 74, 10.1016/j.scr.2011.07.003
Campagnoli, 2001, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow, Blood, 98, 2396, 10.1182/blood.V98.8.2396
In 't Anker, 2004, Isolation of mesenchymal stem cells of fetral or maternal origin from human placenta, Stem Cells, 22, 1338, 10.1634/stemcells.2004-0058
Ryu, 2012, Tonsil-derived mesenchymal stromal cells: Evaluation of biologic, immunologic and genetic factors for successful banking, Cytotherapy, 14, 1193, 10.3109/14653249.2012.706708
Toma, 2001, Isolation of multipotent adult stem cells from the dermis of mammalian skin, Nat Cell Biol, 3, 778, 10.1038/ncb0901-778
Kern, 2006, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells, 24, 1294, 10.1634/stemcells.2005-0342
Wagner, 2005, Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood, Exp Hematol, 33, 1402, 10.1016/j.exphem.2005.07.003
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
Sohn, 2013, Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation, Cytotherapy, 15, 460, 10.1016/j.jcyt.2012.10.015
Choudhery, 2012, Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities, Cell Biol Int, 36, 747, 10.1042/CBI20110183
Jääger, 2011, Human dermal fibroblasts exhibit delayed adipogenic differentiation compared with mesenchymal stem cells, Stem Cells Dev, 20, 1327, 10.1089/scd.2010.0258
Ménard, 2013, Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application, Stem Cell Res Ther, 4, 64, 10.1186/scrt214
Bianco, 2001, Bone marrow stromal stem cells: nature, biology, and potential applications, Stem Cells, 19, 180, 10.1634/stemcells.19-3-180
Kemp, 2005, Bone marrow-derived mesenchymal stem cells, Leuk Lymphoma, 46, 1531, 10.1080/10428190500215076
Bieback, 2004, Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood, Stem Cells, 22, 625, 10.1634/stemcells.22-4-625
Evangelista, 2008, Placenta-derived stem cells: new hope for cell therapy?, Cytotechnology, 58, 33, 10.1007/s10616-008-9162-z
Ikegame, 2011, Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy, Cytotherapy, 13, 675, 10.3109/14653249.2010.549122
Sousa, 2014, Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications, Cytometry A, 85, 43, 10.1002/cyto.a.22402
Wagner, 2008, Replicative senescence of mesenchymal stem cells: a continuous and organized process, PLoS One, 3, e2213, 10.1371/journal.pone.0002213
Yoon, 2011, Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture, Cell Prolif, 44, 428, 10.1111/j.1365-2184.2011.00770.x
Kishi, 2000, Requirement of Sox2-mediated signaling for differentiation of early Xenopus neuroectoderm, Development, 127, 791, 10.1242/dev.127.4.791
Djouad, 2010, Activin A expression regulates multipotency of mesenchymal progenitor cells, Stem Cell Res Ther, 1, 11, 10.1186/scrt11
Shi, 2011, Immunomodulatory properties and therapeutic application of mesenchymal stem cells, Clin Exp Immunol, 164, 1, 10.1111/j.1365-2249.2011.04327.x
Nasef, 2007, Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G, Transplantation, 84, 231, 10.1097/01.tp.0000267918.07906.08
Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554
Bunnell, 2010, New concepts on the immune modulation mediated by mesenchymal stem cells, Stem Cell Res Ther, 1, 34, 10.1186/scrt34
Kim, 2013, Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders, Tissue Eng Reg Med, 10, 93, 10.1007/s13770-013-0010-7
Grütz, 2005, New insights into the molecular mechanism of interleukin-10-mediated immunosuppression, J Leukoc Biol, 77, 3, 10.1189/jlb.0904484
Marie, 2005, TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J Exp Med, 201, 1061, 10.1084/jem.20042276
Nasef, 2007, Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells, Gene Expr, 13, 217, 10.3727/000000006780666957
Martinez, 2007, Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs, Blood, 109, 4245, 10.1182/blood-2006-08-039347
Harada, 2003, Control of osteoblast function and regulation of bone mass, Nature, 423, 349, 10.1038/nature01660
Long, 2003, DLX5 regulates development of peripheral and central components of the olfactory system, J Neurosci, 23, 568, 10.1523/JNEUROSCI.23-02-00568.2003
Phinney, 1999, Donor variation in the growth properties and osteogenic potential of human marrow stromal cells, J Cell Biochem, 75, 424, 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8
Portalska, 2013, The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells, Tissue Eng Part A, 19, 2318, 10.1089/ten.tea.2012.0646
Ho, 2008, Heterogeneity of mesenchymal stromal cell preparations, Cytotherapy, 10, 320, 10.1080/14653240802217011
Li, 2013, Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes, Biotechnol Adv, 31, 312, 10.1016/j.biotechadv.2012.12.003
Sivasubramaniyan, 2012, Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets, Ann NY Acad Sci, 1266, 94, 10.1111/j.1749-6632.2012.06551.x
Noer, 2006, Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue, Mol Biol Cell, 17, 3543, 10.1091/mbc.E06-04-0322
Dominici, 2009, Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa, Transplantation, 87, S36, 10.1097/TP.0b013e3181a283ee